超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

加拿大SQI Diagnostics Inc
SQI Diagnostics Inc. (多倫多，Toronto)是專精于發(fā)展實(shí)驗(yàn)室級生物標(biāo)識分子檢測的醫(yī)療系統(tǒng)自動化的公司， 宣布公司已寄運(yùn)一套Automated Multi–Biomarker SQiDworks(TM)多重生物標(biāo)識分子自動化檢測平臺產(chǎn)品到美國Ohio州的Cleveland Clinic臨床中心。這個研究中心的實(shí)驗(yàn)室是公司第二個在外部通過驗(yàn)證，而取得這個檢測平臺運(yùn)作資格的伙伴。公司將評估這套系統(tǒng)在配合使用SQI Diagnostics' QuantiSpot(TM) RA assay檢測時，其在分析能力方面之表現(xiàn)。公司也將利用該系統(tǒng)所得到的數(shù)據(jù)來作為法規(guī)申請的基礎(chǔ)文件。公司的執(zhí)行長Claude Ricks先生指出，一旦公司的科技平臺可以在美國尖端的醫(yī)院中進(jìn)行效能驗(yàn)證，對公司而言，這己經(jīng)是重要的科技成就。同時，這也證明這些醫(yī)院有意愿在進(jìn)行大量多重生物標(biāo)識分子檢測分析時，可以擁有突破性科技來節(jié)省時間和金錢。公司期待在2008上半年內(nèi)可以完成驗(yàn)證測試，之后并可以將這些數(shù)據(jù)結(jié)果用于支持法規(guī)審核申請案

SQI's proprietary technologies enable Confidence, Profit and Growth for leading diagnostic laboratories that perform autoimmune testing. We provide laboratories the ability to simultaneously analyze multiple biomarkers, deliver accurate and quantitative patient results in less time, significantly reduce labor and increase profits...All in One Drop.

The company is focused on improving the confidence and profitability of laboratory diagnostic testing. Our first product on the SQiDworks? Diagnostics Platform is the QuantiSpot? Assay. This was developed to improve the accuracy of diagnosis of Rheumatoid Arthritis and increase the quality of information that is provided to the physician so they can optimize treatment decisions for each patient.

Thank you for taking a few minutes to explore our website and to learn more about SQI's revolutionary in-vitro multiplexing diagnostic testing. We look forward to the opportunity to meet you and share the full capabilities and benefits we can deliver to your business.